BPC-157

BPC-157 stands for Body Protection Compound 157. It is a synthetic peptide made up of 15 amino acids, derived from a protective protein that your stomach naturally produces in its gastric juice. Scientists first described it in 1992, and since then it has become one of the most talked-about compounds in the fitness and biohacking communities because of its reported ability to speed up recovery from injuries like torn tendons, muscle strains, and gut damage.

Your stomach already makes the parent protein that BPC-157 comes from, and that protein plays an important role in protecting and repairing your gastrointestinal lining every day. The synthetic version isolates the most active fragment of that larger protein and has been studied extensively in animal models for regenerative effects on tendons, ligaments, muscles, bones, and the gut. One remarkable property that sets BPC-157 apart from other peptides is its unusual stability in stomach acid -- it can remain intact for more than 24 hours in the harsh gastric environment, which means it may be effective when taken by mouth.

Despite very promising results in animal studies, BPC-157 is not approved by the FDA for human use. In 2022, the World Anti-Doping Agency banned it, and in 2023 the FDA classified it as a Category 2 bulk drug substance, effectively barring its use in compounded medications due to safety concerns and the lack of human clinical data. The vast majority of research has been done in rodents and other animal models, so anyone considering this compound should understand that its benefits in humans are not yet confirmed by large-scale clinical trials.

One of BPC-157's primary healing actions involves stimulating angiogenesis, which is the creation of new blood vessels. When tissue is damaged, blood supply is critical because blood delivers oxygen, nutrients, and immune cells to the injury site. BPC-157 activates a specific pathway called VEGFR2, which triggers the production of nitric oxide -- a molecule that causes blood vessels to widen and signals the body to build new ones. This improved blood flow to injured areas is one of the key reasons the peptide appears to accelerate healing.

BPC-157 also activates a pathway called FAK-paxillin, which helps cells migrate to injury sites and anchor themselves in place. This is essential for wound healing because cells need to physically move into damaged areas and attach to surfaces before they can start rebuilding tissue. At the same time, the peptide increases fibroblast activity, which ramps up collagen production and tissue remodeling -- the processes that actually rebuild the structural framework of tendons, ligaments, and skin.

Research has shown that BPC-157 upregulates growth hormone receptor expression in tendon fibroblasts, which means the cells that repair your tendons become more responsive to growth hormone. It also activates the ERK1/2 signaling pathway, which plays a central role in cell growth, proliferation, and migration. On the inflammation side, BPC-157 modulates the inflammatory response to prevent excessive tissue damage while still allowing the necessary healing inflammation to proceed, recruiting white blood cells like macrophages and neutrophils that clear away cellular debris and set the stage for new tissue growth.